| Unrelated umbilical cord blood unit selection. | |
| | |
MedLine Citation:
|
PMID: 20109608 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The aims of this review are to summarize the relevant published literature regarding cord blood (CB) graft characteristics and their impact on transplantation outcomes, to present new analyses from patients transplanted with CB units from the New York Blood Center's National Cord Blood Program, and to propose new guidelines for prioritizing CB unit selection. |
| | |
Authors:
|
Andromachi Scaradavou; |
Related Documents
:
|
9715868 - The placental blood program of the barcelona cord blood bank. 1249588 - Spinal cord blood flow after acute experimental cord injury in dogs. 12533578 - Sustained spinal cord compression: part ii: effect of methylprednisolone on regional bl... 12181698 - The pathophysiology of syringomyelia - historical overview and current concept. 3366028 - Relationship between parietal blood flow studies in the left colon and the rectum in do... 7423048 - Structural characteristics in regional versus global ischemia. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Seminars in hematology Volume: 47 ISSN: 1532-8686 ISO Abbreviation: Semin. Hematol. Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2010-01-29 Completed Date: 2010-04-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0404514 Medline TA: Semin Hematol Country: United States |
Other Details:
|
Languages: eng Pagination: 13-21 Citation Subset: IM |
Copyright Information:
|
(c) 2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
National Cord Blood Program, New York Blood Center, New York, NY 11101, USA. ascaradavou@nybloodcenter.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Donors
/
supply & distribution* Cell Count Cord Blood Stem Cell Transplantation* / adverse effects HLA Antigens / genetics, immunology Hematologic Diseases / immunology, surgery* Hematologic Neoplasms / immunology, surgery Hematopoietic Stem Cell Transplantation* / adverse effects Histocompatibility Testing Humans New York City Patient Selection* Pedigree Practice Guidelines as Topic Program Development Recurrence Time Factors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/HLA Antigens |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Umbilical Cord Blood Transplantation: The First 20 Years.
Next Document: Unrelated Umbilical Cord Blood Transplantation and Immune Reconstitution.